Medicare AdvantageCoverageMedium impact
MA11.056h, Percutaneous Transluminal Angioplasty (PTA) Concurrent with or without Stenting and Extracranial- Intracranial (EC-IC) Arterial Bypass Surgery
Independence Blue Cross·Cardiology, Vascular Surgery, Neurosurgery +1 more·Medical Policy
Effective date
Apr 2, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.056h for Percutaneous Transluminal Angioplasty (PTA) with or without stenting and extracranial-intracranial arterial bypass surgery has been reissued and will take effect April 2, 2025. This update may affect coverage criteria, billing requirements, or documentation standards for these vascular procedures.
Action Required
By April 2, 2025: Billing team must review the full policy MA11.056h at the provided URL to identify specific changes to coverage criteria, prior authorization requirements, or documentation standards for PTA procedures with or without stenting and EC-IC bypass surgery. Update billing workflows and provider documentation requirements accordingly for Medicare Advantage claims.